Employee Mental Health

London, United Kingdom

50% Raised

Short Summary

Tlero; a clinically backed platform to improve their mental health in the workplace; Brand Ambassador England Rugby World Cup Winner Ben Cohen; Won 'People's Choice Award' at BT Better World Challenge(2018); Early Revenue Generating

Overview

Target
£300,000
Minimum
£30,000
Investment Raised
£150,000
Previous Rounds £500,000
Stage Achieving Sales
Investor Role Any

Highlights

  • Brand Ambassador: Former England Rugby World Cup Winner Ben Cohen
  • Proposals with cargo & freight organization of 45k+ employees
  • International traction with users in US and Canada
  • Won 'People's Choice Award' at BT Better World Challenge (2018)
  • 100% client retention
Please note: The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
0% raised

Medics Academy

location_on London, United Kingdom

Imagine training all healthcare professionals a country needs through one system. Pilot with NHS; commercial contracts in place; 2,500+ users in Year 1

£ 1,000,000

Target

£ 1,000

Min per Investor

Pro
20% raised

RaySense

location_on South East, United Kingdom

RaySense; Advanced analytics & data modelling platform for healthcare market; Prototype installed in 24+ homes; London NHS Trust & world-renowned research University collaboration; 150+ yrs combined team experience; MVP developed;

£ 50,000

Target

£ 5,000

Min per Investor

Pro
0% raised

Blood Coagulation monitor

location_on W. Midlands, United Kingdom

Bio-AMD have developed a highly sensitive blood coagulation system to measure INR levels of patients after cardiac heart attack, ensure that the patients drug treatment does not lead to clotting or bleed scenario. The system out perform competitors

£ 1,500,000

Target

£ 100

Min per Investor

load one similar proposal